Gala vs Wellorithm: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

53 providers verified independently·Independent research·How we rank →

Visit Wellorithm - our pick of these two→or find your match

Wellorithm beats Gala overall, scoring 7.4/10 vs 7.2/10. Wellorithm is more affordable at $147/mo vs $149/mo. Choose Gala for tirzepatide-first patients who want a low-cost compounded pa. Choose Wellorithm for cash-pay patients who want compounded semaglutide or tirzepa.

A side-by-side look at Gala and Wellorithm to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Gala

#39 of 53

7.2/10

Telehealth platform focused on compounded tirzepatide, both microdose and full-dose tiers, alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.

Visit Gala

Higher Rated

Wellorithm

#29 of 53

7.4/10

Telehealth platform for compounded semaglutide and tirzepatide that uniquely offers BOTH injectable and oral dissolving tablet formats, paired with a 10% weight-loss guarantee that refunds up to four months of program fees if the patient does not lose at least 10% of baseline weight after 16 weeks of medication adherence (terms apply). 28-day recurring billing, non-refundable per-cycle, with a documented address listed in Berlin, Germany.

Visit Wellorithm

Feature	Gala	Wellorithm
Our Score	7.2/10	7.4/10
Starting Price	$149/mo	$147/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated iOS + Android tracker app for daily progress logging	Cash-pay patients who want compounded semaglutide or tirzepatide in a rare oral dissolving tablet format, backed by a 10% weight-loss money-back guarantee and 24/7 support
Watch out for	Brand-name Ozempic here is $1,299/mo, materially above market (NovoCare direct pricing for Wegovy is $349/mo; Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership). Buy brand-name elsewhere, Gala's value is its compounded tirzepatide.	Founding year, corporate ownership, and named prescribers are NOT publicly disclosed, and the only address listed is a German one (Berlin, DE 81566), unusual for a platform serving US patients; if disclosed leadership matters to you, weigh this first
Ranking	#39	#29
Get started	Visit Gala	Visit Wellorithm

Pros & Cons Compared

Gala

Pros

+Microdose compounded tirzepatide at $149/mo, the cheapest microdose tirz on a tracked telehealth platform; full-dose compounded tirzepatide at $179/mo (yearly plan) or $199/mo (3-month plan)
+Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android, first-party in-treatment logging is uncommon among compounded-only platforms
+OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
+All 50 states, free shipping, no insurance required, 24/7 patient support claimed

Cons

−Brand-name Ozempic here is $1,299/mo, materially above market (NovoCare direct pricing for Wegovy is $349/mo; Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership). Buy brand-name elsewhere, Gala's value is its compounded tirzepatide.
−Tirzepatide-only on the compounded side, compounded semaglutide is NOT offered, a narrower medication menu than peers like Maximus, Ro, or Henry Meds
−Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill
−Initial consultation is typically a sync video visit, but ongoing follow-ups are chat-based (no scheduled ongoing video access), and there are no published labs, no named medical director, no specialty obesity oversight
−Restrictive refund policy, Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
−Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn), limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself

Wellorithm

Pros

+Compounded GLP-1 available in BOTH injectable AND oral dissolving tablet formats, semaglutide and tirzepatide each in two formats, broader format menu than most compounded-only platforms
+10% weight-loss money-back guarantee: patients who don't lose at least 10% of baseline weight after 16 weeks of medication adherence may be eligible for refund of up to four months of program fees (verified weight documentation required)
+Competitive entry pricing, $147/mo compounded semaglutide and $249/mo compounded tirzepatide put Wellorithm near the cheaper end of the compounded market
+2-minute qualification quiz, virtual consultation, 24/7 support availability claimed
+23,000+ reviews and 4.9-star rating reported (volume is unusually high for this market segment, verify on independent third-party sources before relying on it)
+Spring promotion advertised at $147 with free shipping included

Cons

−Founding year, corporate ownership, and named prescribers are NOT publicly disclosed, and the only address listed is a German one (Berlin, DE 81566), unusual for a platform serving US patients; if disclosed leadership matters to you, weigh this first
−49 states only, service is unavailable in Louisiana and outside the United States
−Billing runs on a 28-day recurring cycle and payments are non-refundable once processed, with no proration for partial months; cancel before your next cycle processes to avoid paying for an unused month
−Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo; FDA does not review compounded medications for safety, effectiveness, or manufacturing quality
−The weight-loss guarantee has strict eligibility terms: verified weight documentation (doctor attestation or video evidence), prior medication history disclosure, consistent dosing adherence, and refund processed within 30 days of approval, with only fees actually paid refundable and baseline payments non-refundable; document your starting weight from day one if you plan to rely on it
−Two different affiliate landing pages (campaign-7 and qoroxapi/lead.php direct route) run different funnel structures, so the post-click experience can vary

Our Verdict

Wellorithm edges out Gala with a score of 7.4/10 vs 7.2/10. If budget is your priority, Wellorithm starts at $147/mo compared to Gala's $149/mo. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Gala if you want: tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated ios + android tracker app for daily progress logging. Choose Wellorithm if you want: cash-pay patients who want compounded semaglutide or tirzepatide in a rare oral dissolving tablet format, backed by a 10% weight-loss money-back guarantee and 24/7 support.

Still undecided? Editor's Featured Pick

TrimRx

$149/mo · 7.8/10 · Compounded

If neither Gala nor Wellorithm feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.

Visit TrimRx→Read our full TrimRx review